Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-11-23 5:02 pm Purchase | 13D | ITERUM THERAPEUTICS LTD ITRM | Sarissa Capital Management LP | 19,292,768 30.95% | 19,292,768 (New Position) | View |
| 2020-11-09 09:59 am Sale | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 0 0% | -12,493,000 (Position Closed) | View |
| 2020-02-26 5:02 pm Purchase | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 12,493,000 7.9% | 3,000,800 (+31.61%) | View |
| 2020-01-07 4:35 pm Sale | 13D | MEDICINES COMPANY MDCO | Sarissa Capital Management LP | 0 0% | -4,152,000 (Position Closed) | View |
| 2020-01-02 9:59 pm Purchase | 13D | REGULUS THERAPEUTICS INC RGLS | Sarissa Capital Management LP | 7,935,322 29.38% | 4,231,620 (+114.25%) | View |
| 2019-05-30 5:26 pm Purchase | 13D | MEDICINES COMPANY MDCO | Sarissa Capital Management LP | 4,152,000 5.62% | 4,152,000 (New Position) | View |
| 2019-05-17 4:47 pm Purchase | 13D | REGULUS THERAPEUTICS INC RGLS | Sarissa Capital Management LP | 3,703,702 16.53% | 3,703,702 (New Position) | View |
| 2019-05-16 4:52 pm Purchase | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 9,492,200 6.1% | 9,492,200 (New Position) | View |